Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their top 2026 priority for ...
As cancer care becomes increasingly driven by complex, high-cost therapies, health systems are rethinking how tightly ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...
Cencora is transitioning from a traditional wholesale logistics model to a higher margin specialty services model. Click here to find out why COR is a Buy.
Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...
16d
Onco360(R) Has Been Selected as the National Pharmacy Partner for UNLOXCYT(TM) (cosibelimab-ipdl)
Onco360(R) , the nation's leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT(TM) (cosibelimab-ipdl). UNLOXCYT is the first ...
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results